Nektar Therapeutics | NKTR - Los Ingresos Por Intereses

Precio De Mercado
77.50
Cambio Diario
-0.35 -0.45%
Mensual
5.69%
Anual
736.44%
Q2 Expectativa
75.38




Los Ingresos Por Intereses Cambio Fecha
Agios Pharmaceuticals USD 13.37M 1.14M 2025-09
ALKERMES USD 11.94M 853K 2025-09
Baxter International USD 10M 4M 2025-09
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
Biogen USD 31.6M 700K 2025-09
Cara Therapeutics USD 347K 74K 2025-03
Dr.Reddys Laboratories INR 796M 116M 2025-12
Eisai JPY 3.11B 783M 2024-03
Eli Lilly USD 65M 25M 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Exelixis USD 15.92M 867K 2025-09
Gilead Sciences USD 88M 15M 2025-09
GlaxoSmithKline GBP 26M 24M 2025-09
Incyte USD 30.75M 3.97M 2025-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Ironwood Pharmaceuticals USD 778K 374K 2024-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
MacroGenics USD 1.53M 114K 2025-09
Merck USD 96M 27M 2025-09
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD 0.62 156M 2025-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Takeda JPY 87.87B 43.48B 2025-12
Xencor USD 6.54M 710K 2025-09